Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Illinois Chicago
With
Research to Prevent Blindness
Genentech, Inc.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Aged 18 years or older.
Capable of giving informed consent and does provide informed consent.
Documented Dry Eye Disease for at least 6 months.
Schirmer I \<10
Corneal/ conjunctival (Rose Bengal) staining ≥1
Ocular symptoms must be considered as annoying or activity limiting (OSDI ≥13; mild).
Women must be post-menopausal ≥ 1 year, or surgically sterilized. If not, a negative urine pregnancy test is required within 14 days of receiving her first dose of test medication (placebo/ study drug) along with definite evidence of contraceptive use during the duration of the study.
You may not be if
Allergic to Deoxyribonuclease eye drops or any similar products, or excipients of Deoxyribonuclease eye drops 0.1%.
Receiving or have received within 30 days any experimental systemic medication.
Active ocular infection or ocular allergies.
Any history of eyelid surgery or ocular surgery within the past 3 months.
Corneal epithelial defect larger than 1 mm2 in either eye.
The use of topical cyclosporine or corticosteroids within 2 weeks of enrollment
Have active drug/alcohol dependence or abuse history
